Zealand Pharma is a biotechnology research company that designs and develops peptide-based medicine, mainly within metabolic diseases such as diabetes and obesity. (Archive photo). Photo: Thomas Traasdahl/Ritzau Scanpix
Zealand Pharma shares fall 8.5 percent after weight-loss drug trial results
Shares in Danish biotech company Zealand Pharma fell 8.5 percent Thursday morning after partner Boehringer Ingelheim released results from a late-stage trial of the weight-loss drug survodutide.
Overweight participants with type 2 diabetes lost an average of 13.1 percent of their body weight...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?